Literature DB >> 9636207

KARP-1 is induced by DNA damage in a p53- and ataxia telangiectasia mutated-dependent fashion.

K Myung1, C Braastad, D M He, E A Hendrickson.   

Abstract

The KARP-1 (Ku86 Autoantigen Related Protein-1) gene, which is expressed from the human Ku86 autoantigen locus, appears to play a role in mammalian DNA double-strand break repair as a regulator of the DNA-dependent protein kinase complex. Here we demonstrate that KARP-1 gene expression is significantly up-regulated following exposure of cells to DNA damage. KARP-1 mRNA induction was completely dependent on the ataxia telangiectasia and p53 gene products, consistent with the presence of a p53 binding site within the second intron of the KARP-1 locus. These observations link ataxia telangiectasia, p53, and KARP-1 in a common pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636207      PMCID: PMC22716          DOI: 10.1073/pnas.95.13.7664

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination.

Authors:  Y Gu; S Jin; Y Gao; D T Weaver; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  DNA-PK: at the cross-roads of biochemistry and genetics.

Authors:  P A Jeggo
Journal:  Mutat Res       Date:  1997-06-09       Impact factor: 2.433

Review 3.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

4.  Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle.

Authors:  S E Lee; R A Mitchell; A Cheng; E A Hendrickson
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

Authors:  R Scully; J Chen; R L Ochs; K Keegan; M Hoekstra; J Feunteun; D M Livingston
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

6.  V(D)J recombination. From RAGs to stitches.

Authors:  D T Weaver; F W Alt
Journal:  Nature       Date:  1997-07-31       Impact factor: 49.962

7.  KARP-1: a novel leucine zipper protein expressed from the Ku86 autoantigen locus is implicated in the control of DNA-dependent protein kinase activity.

Authors:  K Myung; D M He; S E Lee; E A Hendrickson
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

8.  Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates.

Authors:  C Zhu; M A Bogue; D S Lim; P Hasty; D B Roth
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

9.  Dual roles of ATM in the cellular response to radiation and in cell growth control.

Authors:  Y Xu; D Baltimore
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

Review 10.  Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction.

Authors:  M F Lavin; Y Shiloh
Journal:  Curr Opin Immunol       Date:  1996-08       Impact factor: 7.486

View more
  12 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  A global genomic view on LNX siRNA-mediated cell cycle arrest.

Authors:  Dan Zheng; Shaohua Gu; Yao Li; Chaoneng Ji; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

Review 3.  The Ku complex: recent advances and emerging roles outside of non-homologous end-joining.

Authors:  Sanna Abbasi; Gursimran Parmar; Rachel D Kelly; Nileeka Balasuriya; Caroline Schild-Poulter
Journal:  Cell Mol Life Sci       Date:  2021-04-15       Impact factor: 9.261

4.  Novel mutations and defective protein kinase C activation of T-lymphocytes in ataxia telangiectasia.

Authors:  M A García-Pérez; L M Allende; A Corell; P Varela; A A Moreno; A Sotoca; A Moreno; E Paz-Artal; E Barreiro; A Arnaiz-Villena
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

5.  Ku86 autoantigen related protein-1 transcription initiates from a CpG island and is induced by p53 through a nearby p53 response element.

Authors:  Corey D Braastad; Mariana Leguia; Eric A Hendrickson
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

6.  Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage.

Authors:  Michael H Brodsky; Brian T Weinert; Garson Tsang; Yikang S Rong; Nadine M McGinnis; Kent G Golic; Donald C Rio; Gerald M Rubin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  Molecular cloning and characterization of rKAB1, which interacts with KARP-1, localizes in the nucleus and protects cells against oxidative death.

Authors:  Eunju Do; Eiichi Taira; Yasuyuki Irie; Yehua Gan; Hidekazu Tanaka; Che-Hui Kuo; Naomasa Miki
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

8.  An investigation of hormesis of trichloroethylene in L-02 liver cells by differential proteomic analysis.

Authors:  Hai-Yan Huang; Jian-Jun Liu; Ren-Rong Xi; Xiu-Mei Xing; Jian-Hui Yuan; Lin-Qing Yang; Gong-Hua Tao; Chun-Mei Gong; Zhi-Xiong Zhuang
Journal:  Mol Biol Rep       Date:  2008-12-25       Impact factor: 2.316

9.  Sepantronium is a DNA damaging agent that synergizes with PLK1 inhibitor volasertib.

Authors:  Mei Hong; Mingqiang Ren; Jeane Silva; Thomas Kennedy; Justin Choi; John K Cowell; Zhonglin Hao
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

Review 10.  The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 2: transcriptional regulation.

Authors:  Panagiotis J Vlachostergios; Anna Patrikidou; Danai D Daliani; Christos N Papandreou
Journal:  J Cell Mol Med       Date:  2009-06-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.